)
Kronox exports to greater than 20 nations with main exports to the US, the UK, Mexico, Australia, and Egypt.
The preliminary public provide of Kronox Lab Sciences obtained 24.57 instances subscription on the second day of bidding on Tuesday.
The IPO obtained bids for 16,45,99,160 shares in opposition to 66,99,000 shares on provide, as per NSE knowledge.
The quota for non-institutional buyers obtained subscribed 52.92 instances whereas the class for Retail Particular person Traders (RIIs) fetched 24.52 instances subscription. The portion for Certified Institutional Consumers (QIBs) obtained 3.39 instances subscription.
The Preliminary Public Provide (IPO) has a suggestion on the market of as much as 95,70,000 fairness shares. The value vary for the IPO is Rs 129-136 a share.
Kronox Lab Sciences has raised Rs 39.04 crore from anchor buyers.
Pantomath Capital Advisors is the supervisor to the provide.
The corporate’s fairness shares are proposed to be listed on the BSE and NSE.
Vadodara-based Kronox Lab Sciences is the producer of high-purity speciality advantageous chemical compounds. Its excessive purity speciality advantageous chemical compounds portfolio has greater than 185 merchandise. The merchandise are used primarily for purposes throughout prescribed drugs, nutraceuticals, biotech, animal well being, scientific analysis, agrochemicals, and private care, amongst others.
Kronox exports to greater than 20 nations with main exports to the US, the UK, Mexico, Australia, and Egypt.
The corporate has 3 manufacturing services and a Analysis, Growth and Testing (RDT) laboratory, located in Vadodara, Gujarat. Moreover, the corporate has acquired land in Dahej, Gujarat to arrange a brand new manufacturing plant.
(Solely the headline and film of this report might have been reworked by the Enterprise Normal workers; the remainder of the content material is auto-generated from a syndicated feed.)
First Printed: Jun 04 2024 | 7:01 PM IST
)
